基于CT的列线图用于术前预测胰腺神经内分泌肿瘤(pNETs)分级的开发与验证
本研究在两家中心纳入2009年1月至2020年11月经病理确诊的162例pNETs患者,按2017年WHO分类分为G1、G2、G3级,利用LASSO筛选CT影像特征后经多变量logistic回归构建列线图预测肿瘤分级。列线图包含肿瘤边缘、肿瘤大小、神经内分泌症状及门静脉期强化比值,平均AUC为0.848(95%CI 0.918-0.953),内部验证AUC为0.835(95%CI 0.915-0.954),外部验证AUC为0.770(95%CI 0.776-0.789)。作者认为该列线图在本前预测pNETs恶性分级方面表现良好,可为临床医生提供简单、实用、无创的工具用于pNETs患者的个体化管理。
要点
- 列线图纳入肿瘤边缘、肿瘤大小、神经内分泌症状及门静脉期强化比值四项指标预测pNETs分级。
- 列线图平均AUC 0.848(95%CI 0.918-0.953),内部验证AUC 0.835(95%CI 0.915-0.954)。
- 外部验证AUC稍低,为0.770(95%CI 0.776-0.789)。
核心结论
- 基于CT的列线图模型在术前预测pNETs恶性分级方面表现良好,可为临床医生提供简单、实用、无创的工具用于pNETs患者的个体化管理。
研究设计与样本
- 两中心纳入2009年1月至2020年11月经病理确诊的pNETs患者162例,按2017年WHO分类分为G1、G2、G3级,训练集114例、内部验证集21例、外部验证集48例,经LASSO筛选CT影像特征后行多变量logistic回归构建列线图。
诊断标准与关键数值
- 列线图由肿瘤边缘、肿瘤大小、神经内分泌症状及门静脉期图像上肿瘤强化比值构成,用于预测pNETs恶性分级;平均AUC 0.848(95%CI 0.918-0.953),内部验证AUC 0.835(95%CI 0.915-0.954),外部验证AUC 0.770(95%CI 0.776-0.789)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND/PURPOSE: It is challenging to determine the pancreatic neuroendocrine tumors (pNETs) malignancy grade noninvasively. We aim to establish a CT - based diagnostic nomogram to predict the tumor grade of pNETs.
METHODS: The patients with pathologically confirmed pNETs were recruited in two centers between January 2009 and November 2020. PNETs were subdivided into three grades according to the 2017 World Health Organization classification: low-grade G1 NETs, intermediate-grade G2 NETs, and high-grade G3 NETs. The features on the CT images were carefully evaluated. To build the nomogram, multivariable logistic regression analysis was performed on the imaging features selected by LASSO to generate a combined indicator for estimating the tumor grade.
RESULTS: A total of 162 pNETs (training set n = 114, internal validation set n = 21, external validation set, n = 48) were admitted, including 73 (45.1%) G1 and 89 (54.9%) G2/3. A nomogram comprising the tumor margin, tumor size, neuroendocrine symptoms and the enhanced ratio on portal vein phase images of tumor was established to predict the malignancy grade of pNETs. The mean AUC for the nomogram was 0.848 (95% CI, 0.918-0.953). Application of the developed nomogram in the internal validation dataset still yielded good discrimination (AUC, 0.835; 95% CI, 0.915-0.954). The externally validated nomogram yielded a slightly lower AUC of 0.770 (95% CI, 0.776-0.789).
CONCLUSIONS: The nomogram model demonstrated good performance in preoperatively predicting the malignancy grade of pNETs, and can provide clinicians with a simple, practical, and non-invasive tool for personalized management of pNETs patients.
引用
- Wang L, Zhao X, Zhu W, et al. Development and validation of a CT-based nomogram to preoperative prediction of pancreatic neuroendocrine tumors (pNETs) grade. Abdom Radiol (NY). 2025. PMID: 40293523. doi:10.1007/s00261-025-04959-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。